Personal tools

MCL coexpression mm9:449

From FANTOM5_SSTAR

Revision as of 16:11, 10 October 2012 by Autoedit (talk | contribs) (Created page with "{{MCL_coexpression_mm9|gostat_on_MCL_coexpression=GO:0003705;RNA polymerase II transcription factor activity, enhancer binding;1.30825649872795e-06;17927,17877,17928!GO:000751...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Phase1 CAGE Peaks

 Short description
Mm9::chr10:106920848..106920852,-p@chr10:106920848..106920852
-
Mm9::chr10:106923133..106923146,-p1@Myf5
Mm9::chr12:74140323..74140332,+p1@uc007nvz.1
Mm9::chr15:76993525..76993544,-p@chr15:76993525..76993544
-
Mm9::chr15:76993546..76993607,-p@chr15:76993546..76993607
-
Mm9::chr17:45738994..45739005,-p1@Gm7325
Mm9::chr17:45739019..45739035,-p3@Gm7325
Mm9::chr17:45739045..45739057,-p2@Gm7325
Mm9::chr1:136186574..136186592,+p1@Myog
Mm9::chr1:136186599..136186608,+p3@Myog
Mm9::chr2:26927548..26927562,-p4@Tmem8c
Mm9::chr2:26927603..26927613,-p5@Tmem8c
Mm9::chr7:53631818..53631829,+p2@Myod1
Mm9::chr7:53631837..53631850,+p1@Myod1
Mm9::chr8:15060282..15060301,+p6@Myom2
Mm9::chr8:81337088..81337099,-p5@Lsm6


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0003705RNA polymerase II transcription factor activity, enhancer binding1.30825649872795e-06
GO:0007517muscle development2.24385378621871e-06
GO:0003702RNA polymerase II transcription factor activity3.14894467472946e-05
GO:0007519skeletal muscle development4.64273339264029e-05
GO:0014706striated muscle development7.90474854121923e-05
GO:0048741skeletal muscle fiber development0.00221721181591798
GO:0048747muscle fiber development0.00221721181591798
GO:0048513organ development0.00221721181591798
GO:0048625myoblast cell fate commitment0.00369210929248125
GO:0007518myoblast cell fate determination0.00369210929248125
GO:0048731system development0.00369210929248125
GO:0048856anatomical structure development0.00617794943570449
GO:0003700transcription factor activity0.00822184566576725
GO:0007275multicellular organismal development0.00822184566576725
GO:0016070RNA metabolic process0.00895309312046242
GO:0001952regulation of cell-matrix adhesion0.0157891795918016
GO:0010467gene expression0.0157891795918016
GO:0003676nucleic acid binding0.0157891795918016
GO:0008307structural constituent of muscle0.0157891795918016
GO:0032502developmental process0.0167022049410475
GO:0006139nucleobase, nucleoside, nucleotide and nucleic acid metabolic process0.0187434878481659
GO:0048704embryonic skeletal morphogenesis0.0187434878481659
GO:0032982myosin filament0.0203009953927489
GO:0005863striated muscle thick filament0.0203009953927489
GO:0005859muscle myosin complex0.0209858061922863
GO:0016460myosin II complex0.0222023357894868
GO:0048706embryonic skeletal development0.0222023357894868
GO:0048705skeletal morphogenesis0.0286850449302073
GO:0001709cell fate determination0.0286850449302073
GO:0048869cellular developmental process0.0286850449302073
GO:0030154cell differentiation0.0286850449302073
GO:0006402mRNA catabolic process0.0286850449302073
GO:0006941striated muscle contraction0.0286850449302073
GO:0006355regulation of transcription, DNA-dependent0.0286850449302073
GO:0043229intracellular organelle0.0286850449302073
GO:0006351transcription, DNA-dependent0.0286850449302073
GO:0043226organelle0.0286850449302073
GO:0032774RNA biosynthetic process0.0286850449302073
GO:0006401RNA catabolic process0.0286850449302073
GO:0003677DNA binding0.0286850449302073
GO:0005634nucleus0.0286850449302073
GO:0001756somitogenesis0.0286850449302073
GO:0032501multicellular organismal process0.0286850449302073
GO:0045449regulation of transcription0.0286850449302073
GO:0019219regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process0.0288343685554405
GO:0045445myoblast differentiation0.0288343685554405
GO:0043283biopolymer metabolic process0.0288343685554405
GO:0006350transcription0.0288343685554405
GO:0032991macromolecular complex0.0293743797132572
GO:0010468regulation of gene expression0.0303893002783488
GO:0035282segmentation0.0307669318902937
GO:0030155regulation of cell adhesion0.0321065380895143
GO:0031323regulation of cellular metabolic process0.0321065380895143
GO:0019222regulation of metabolic process0.0348980828944188
GO:0030198extracellular matrix organization and biogenesis0.0379645308585611
GO:0016459myosin complex0.0379645308585611
GO:0046982protein heterodimerization activity0.0392486596754975
GO:0042692muscle cell differentiation0.0398010198410609
GO:0007160cell-matrix adhesion0.0398010198410609
GO:0030017sarcomere0.0409223218011252
GO:0031589cell-substrate adhesion0.0409223218011252
GO:0044449contractile fiber part0.0414550571125855
GO:0030016myofibril0.0440876304488212
GO:0044424intracellular part0.0440876304488212
GO:0043292contractile fiber0.0440876304488212
GO:0003012muscle system process0.0460741289802003
GO:0006936muscle contraction0.0460741289802003
GO:0005200structural constituent of cytoskeleton0.0481049369305937
GO:0005622intracellular0.0490378524892453
GO:0009952anterior/posterior pattern formation0.0498838723759717



Relative expression of the co-expression cluster over median <br>Analyst:



"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}